Incyte has revealed promising early clinical data for its potential first-in-class CDK2 inhibitor, INCB123667, in patients with advanced solid tumours. The data, presented at the European…
EDX Medical Group plc, a UK-based innovator in digital diagnostics, has announced a strategic partnership with US precision medicine leader Caris Life Sciences. The deal, which…
Discover precise insights into the intersections of health, society, and culture in the UK at Social Equality. Your reliable source for clear and comprehensive coverage.